ClinicalTrials.gg
CompletedNCT04757675Updated Apr 27, 2022

S-ketamin Premedication in Pediatric EENT Surgery

An Early Phase 1 interventional study of S-ketamine 0.3 and S-ketamine 0.5 in Emotions, Separation Anxiety and Pain, Procedural, sponsored by Eye & ENT Hospital of Fudan University. Completed at 1 site in China. Open to participants aged 2 Years to 12 Years. Per ClinicalTrials.gov, last updated 2022-04-27.

Sponsored by Eye & ENT Hospital of Fudan University · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
320
Allocation
Randomized
Ages
2 Years to 12 Years
Sex
All
01

Study summary

We aim to investigate the effects of premedication (intranasal or intravenous administration) of s-ketamin, dexmedetomidine, and combination for premedication in children undergoing ENT surgery.

Read the detailed description

Three hundred children aged between 2 and 12 years were randomly allocated to one of five groups: 0.3 μg/kg intravenous injection s-ketamin; 0.5 μg/kg intravenous injection s-ketamin; 2 μg/kg intranasal s-ketamin group; 1 μg/kg intranasal s-ketamin + 1 μg/kg intranasal dexmedetomidine group; 0.5 μg/kg intranasal s-ketamin + 2 μg/kg intranasal dexmedetomidine group.

The modified Yale Preoperative Anxiety Scale (m-YPAS) was used to assess preoperative anxiety at 1, 5, 10, 20, and 30min after premedication. A 4-point emotional state score was used to evaluate participators when they were separated from their parents and their response to intravenous cannulation or facemask application. Agitation scores (Pediatric Anesthesia Emergence Delirium [PAED] scale) and POV was assessed in the postanesthetic care unit (PACU). Times to endotracheal tube or laryngeal mask airway removal, discharge from the PACU, and patients' satisfaction degree were also assessed.

02

Conditions studied

  • Emotions
  • Separation Anxiety
  • Pain, Procedural
03

In context

Anxiety, Separation

59 studies on the registry are indexed under Anxiety, Separation; 5 are open to participants now.

This study's enrollment of 320 is above the median of 68 across 53 interventional studies indexed under Anxiety, Separation.

Browse Anxiety, Separation studies →

Lead sponsor

Eye & ENT Hospital of Fudan University is the lead sponsor of 126 studies on the registry; 70 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • After obtaining the from their parents or proxies, the children aged 2 to 12 years, scheduled for elective ENT surgery, of (ASA) I or II were enrolled in this study.

Exclusion criteria

Exclusion Criteria:

  • Congenital heart diseases, congenital dysplasia, obstructive sleep apnea syndrome, upper respiratory tract infection, (BMI) ≥25, allergy to S-ketamin or dexmedetomidine, and severe liver or kidney disease.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
320 participants (actual)

Study arms

  • Experimental
    0.3 SK iv

    0.3 μg/kg intravenous injection s-ketamin

    Drug: S-ketamine 0.3

  • Experimental
    0.5 SK iv

    0.5 μg/kg intravenous injection s-ketamin

    Drug: S-ketamine 0.5

  • Experimental
    2 SK in

    2 μg/kg intranasal s-ketamin

    Drug: S-ketamine 2

  • Experimental
    1 SK in + 1 DEX in

    1 μg/kg intranasal s-ketamin + 1 μg/kg intranasal dexmedetomidine

    Drug: S-ketamine 1+Dexmedetomidine 1

  • Experimental
    0.5 SK in + 2 DEX in

    0.5 μg/kg intranasal s-ketamin + 2 μg/kg intranasal dexmedetomidine

    Drug: S-ketamine 0.5 +Dexmedetomidine 2

Interventions

  • DrugS-ketamine 0.3

    0.3 μg/kg intravenous injection s-ketamin

    Also known as: Jiangsu Hengrui Medicine Co.,Ltd.

  • DrugS-ketamine 0.5

    0.5 μg/kg intravenous injection s-ketamin

    Also known as: Jiangsu Hengrui Medicine Co.,Ltd.

  • DrugS-ketamine 2

    2 μg/kg intranasal s-ketamin

    Also known as: Jiangsu Hengrui Medicine Co.,Ltd.

  • DrugS-ketamine 1+Dexmedetomidine 1

    1 μg/kg intranasal s-ketamin + 1 μg/kg intranasal dexmedetomidine

    Also known as: Jiangsu Hengrui Medicine Co.,Ltd.

  • DrugS-ketamine 0.5 +Dexmedetomidine 2

    0.5 μg/kg intranasal s-ketamin + 2 μg/kg intranasal dexmedetomidine

    Also known as: Jiangsu Hengrui Medicine Co.,Ltd.

06

What researchers measure

Primary outcomes

  1. The modified Yale Preoperative Anxiety Scale

    A validated observational tool for assessing children's anxiety

    Time frame: 1 min after premedication

  2. The modified Yale Preoperative Anxiety Scale

    A validated observational tool for assessing children's anxiety

    Time frame: 5 min after premedication

  3. The modified Yale Preoperative Anxiety Scale

    A validated observational tool for assessing children's anxiety

    Time frame: 10 min after premedication

  4. The modified Yale Preoperative Anxiety Scale

    A validated observational tool for assessing children's anxiety

    Time frame: 20 min after premedication

  5. The modified Yale Preoperative Anxiety Scale

    A validated observational tool for assessing children's anxiety

    Time frame: 30 min after premedication

Secondary outcomes

  1. Parental Separation Anxiety Scale (PSAS)

    1. = easy separation 2. = whimpers, but is easily reassured, not clinging 3. = cries and cannot be easily reassured, but not clinging to parents 4. = crying and clinging to parents

    Time frame: 30 min after premedication

  2. Emotional State Scale

    Successful venous cannulation was defined as an ESS-4 ≤2 at the time of attempted cannulation, regardless of whether the vein was actually cannulated on the first attempt.

    Time frame: 15 min after premedication

07

Study locations

1 site
  • Eye and ENT Hospital of Fudan University
    Shanghai, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04757675
Responsible party
Hui Qiao (Clinical Anesthesiologist, Eye & ENT Hospital of Fudan University) — Principal investigator
First posted
Feb 17, 2021
Start date
Mar 1, 2021
Primary completion
Sep 1, 2021
Completion
Jan 1, 2022
Last update
Apr 27, 2022

Study contacts

Hui Qiao, M.D.
principal investigator · Eye and ENT Hospital of Fudan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion